CCCC vs GILD: Which Stock is Better?
Side-by-side comparison of C4 Therapeutics Inc and Gilead Sciences Inc in 2026
CCCC
C4 Therapeutics Inc
$2.97
GILD
Gilead Sciences Inc
$130.40
Key Metrics Comparison
| Metric | CCCC | GILD | Winner |
|---|---|---|---|
| Market Cap | $299.56M | $165.87B | GILD |
| P/E Ratio | N/A | 19.71 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 1.1% | 0.0% | CCCC |
| Gross Margin | 75.0% | 78.8% | GILD |
Analyze CCCC
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CCCC or GILD a better investment?
Comparing CCCC and GILD: C4 Therapeutics Inc has a market cap of $299.56M while Gilead Sciences Inc has $165.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CCCC and GILD?
CCCC (C4 Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CCCC or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CCCC or GILD?
CCCC has higher revenue growth at 1.1% vs 0.0% for GILD.
Which company is more profitable: CCCC or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 75.0% for CCCC.
Which is the larger company: CCCC or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $165.87B compared to $299.56M for CCCC.
Should I buy CCCC or GILD in 2026?
Both CCCC and GILD have investment merit. CCCC trades at $2.97 while GILD trades at $130.40. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CCCC and GILD stock?
Key differences: Market Cap ($299.56M vs $165.87B), P/E Ratio (N/A vs 19.7x), Revenue Growth (1.1% vs 0.0%), Gross Margin (75.0% vs 78.8%).